INTRODUCTION
Breast cancer is thought to be largely preventable through dietary and hfestyle modifications. Low levels of folate and related B vitamins both in diet and in circulating have been associated with risk of breast cancer in several prospective epidemiologic studies. Folate, a B vitamin mostly found in vegetables and fruits, is a crucial component in DNA methylation as well as DNA synthesis, both of which are important processes in etiology of breast cancer. Certain genes involved in these processes differ from on person to another. Therefore, a portion of the general population with inherited suboptimal folate metabolism along with low folate intake may be at increased risk of developing breast cancer. We plan to utilize resource of the Long Island Breast Cancer Project, a large population-based case-control study, to study both nutritional and genetic aspects of the disease. We will investigate: (1) whether dietary folate is a micronutrient that is protective against breast cancer; (2) whether a proportion of the population with inherited sub-optimal folate metabolism is at increased risk of breast cancer; (3) whether such inherited variability modifies the association of folate intake and risk of breast cancer; and (4) whether folate may interact with alcohol that interrupts folate metabohsm in contributing to risk of breast cancer. The significance of this research lies in its potential not only to clarify etiology of breast cancer but also to guide the prevention of breast cancer through dietary modification. Furthermore, because a high proportion of the general population may inherit sub-optimal folate metabolism, attributable risk associated with these genetic factors may be quite significant. Associations between such susceptibility and risk of breast cancer will provide an extremely valuable guide to preventive dietary and other lifestyle modifications in individuals and in the population at large.
BODY Task 1: To investigate the association of folate intake with risk of breast cancer in the Long Island Breast Cancer Study Project (Month 1-12).
We have computed dietary levels of B vitamins from the dietary questionnaire of the LEBSCP. These micronutrients, folate, vitamin Bl, B2, B6, and Niacin, are highly correlated with Pearson Coefficient > 0.8. We have built logistic regression models to assess risk of breast cancer associated B vitamins. Our findings are summarized below:
A. Overall association of dietary B vitamins and risk of breast cancer (Table 1) .
Overall, increased dietary intake of B vitamins was associated with reduced risk of breast cancer with ORs < 1; however, the reduction is very modest. For example, compared to those in the lowest quintile of dietary folate intake, individuals in the highest quintile of folate intake had a 12% reduction in breast cancer risk (OR 0.88, 95%CI 0.68-1.14). Similar relations were also observed with other B vitamins.
B. Associations of B vitamins and breast cancer sfratified multivitamin use (Table 2 ).
The most interesting findings so far is that there is a significant dose-relationship between dietary B vitamin intake and breast cancer only among non-multivitamin users (p, trend = 0.01). Among non-multivitamin users, individuals with high dietary B vitamin intakes had significantly reduced risk of breast cancer compared to those with low intakes. The ORs (5* vs. 1'' quintile) were 0.57 (95%CI 0.39-0.84), 0.62 (95%CI 0.42-0.90), 0.59 (95%CI 0.41-0.86), 0.65 (95%CI 0.39-0.94) for folate, niacin, Bl and B2, respectively. Multivitamin use was not associated with breast cancer risk (OR=0.96, 95%CI 0.82-1.13). Among the users (-50%), dietary folate was not related to breast cancer risk (p, trend = 0.90).
C. Associations of B vitamins and breast cancer stratified by menopausal status and tumor characteristics (Table 3a , b). We examined whether the associations of B vitamins and breast cancer were different with menopausal status (pre-vs. post-) and tumor characteristics (invasive vs. in situ) by stratified analyses. It appears that these associations were slightly stronger for postmenopausal and invasive breast cancer as shown in the test for trend. But no significant effect modification was reported.
D. Interaction of alcohol consumption and folate intake in relation to breast cancer ( Figure 1 ).
Interactions of alcohol and folate intake in relation to breast cancer has been observed in three large cohort studies, i.e. the Nureses' Health Study, the Canadian National Breast Screen Study and the Iowa Women's Health Study. We observed the significant association between folate intake and breast cancer only among non-alcohol users (p, trend = 0.04). Compared the non-alcohol users, high folate intake (5* quintile) was associated with 34% reduction in risk (OR 0.66, 95%CI 0.49-0.90). B. MTHFR polymorphisms (Table 4) .
Genotyping for MTHFR 677C->T polymorphism has been completed and resuhs are summarized in Table 4 . The genotype distribution of the control population of the LIBCSP was 47% CC, 39%CT and 14%TT, similar to other US populations. The prevalence of TT genotype is 17% in cases, sUghtly higher than controls with OR of 1.37 (95%)CI 1.02-1.77) ( Table 4a ). The increased risk was more pronounced in women who are pre-menopausal (Table 4) , use multivitamin (Table 4c ), drinks alcohol (Table 4d) .
We also observed a significant interaction between MTHFR polymorphism and total folate intake (p, interaction = 0.03) (Figure 2 
